22202101|t|The role of mTOR signaling in Alzheimer disease.
22202101|a|The buildup of Abeta and tau is believed to directly cause or contribute to the progressive cognitive deficits characteristic of Alzheimer disease. However, the molecular pathways linking Abeta and tau accumulation to learning and memory deficits remain elusive. There is growing evidence that soluble forms of Abeta and tau can obstruct learning and memory by interfering with several signaling cascades. In this review, I will present data showing that the mammalian target of rapamycin (mTOR) may play a role in Abeta and tau induced neurodegeneration.
22202101	12	16	mTOR	Gene	2475
22202101	30	47	Alzheimer disease	Disease	MESH:D000544
22202101	64	69	Abeta	Gene	351
22202101	74	77	tau	Gene	4137
22202101	141	159	cognitive deficits	Disease	MESH:D003072
22202101	178	195	Alzheimer disease	Disease	MESH:D000544
22202101	237	242	Abeta	Gene	351
22202101	247	250	tau	Gene	4137
22202101	267	295	learning and memory deficits	Disease	MESH:D007859
22202101	360	365	Abeta	Gene	351
22202101	370	373	tau	Gene	4137
22202101	508	537	mammalian target of rapamycin	Gene	2475
22202101	539	543	mTOR	Gene	2475
22202101	564	569	Abeta	Gene	351
22202101	574	577	tau	Gene	4137
22202101	586	603	neurodegeneration	Disease	MESH:D019636
22202101	Association	MESH:D000544	4137
22202101	Association	2475	351
22202101	Association	MESH:D019636	2475
22202101	Association	MESH:D007859	351
22202101	Positive_Correlation	MESH:D019636	4137
22202101	Association	MESH:D000544	2475
22202101	Association	MESH:D003072	351
22202101	Association	MESH:D007859	4137
22202101	Positive_Correlation	MESH:D019636	351
22202101	Association	2475	4137
22202101	Association	MESH:D000544	351
22202101	Association	MESH:D003072	4137

